Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, May 9, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
Home
Authors
Posts by admin
admin
1872 POSTS
6 COMMENTS
Latest Pharma-News
U.S. FDA approved BMS Breakthrough Therapy Designation for ORENCIA® (abatacept) just to help in Preventing Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication...
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Investigational New Drug (IND) application for Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
admin
-
December 5, 2019
0
Latest Pharma-News
Ardelyx’s kidney disease drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD)
admin
-
December 5, 2019
0
Latest Pharma-News
United States Food and Drug Administration (USFDA) approved Bortezomib for Injection (IV) 3.5 mg/vial for the treatment of cancers in adult patients
admin
-
December 5, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Regenerative Medicine Advanced Therapy (RMAT) designation from the for ADP-A2M4 for the treatment of synovial...
admin
-
December 5, 2019
0
Latest Pharma-News
Immunomedics Resubmits Biologics License Application to FDA for the treatment of metastatic triple-negative breast cancer (mTNBC)
admin
-
December 4, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration (FDA) has cleared the Atreca’s Investigational New Drug (IND) application for first-in-human Phase 1b clinical trial of ATRC-101...
admin
-
December 4, 2019
0
Latest Pharma-News
OSE Immunotherapeutics Announces Positive Results from first-in-human dose-escalation, randomized, double-blind, placebo-controlled Phase 1 trial of Anti-IL-7 Receptor Antagonist OSE-127
admin
-
December 4, 2019
0
Latest Pharma-News
AstraZeneca divests rights Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in the US and Canada to Cheplapharm Arzneimittel GmbH...
admin
-
December 4, 2019
0
Latest Pharma-News
Co-Diagnostics Gets “Indian FDA” Approval for Infectious Disease Testing (in vitro diagnostic assays)in One of the World’s Biggest Markets
admin
-
December 4, 2019
0
Clinical Research
The History of clinical research
admin
-
December 3, 2019
0
Latest Pharma-News
FDA approved Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
admin
-
December 3, 2019
0
1
...
150
151
152
...
156
Page 151 of 156
TOP AUTHORS
admin
1872 POSTS
6 COMMENTS
OIdMIHuOdiu
0 POSTS
0 COMMENTS
tintin
0 POSTS
0 COMMENTS
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025